TFRI News|April 15, 2024 2025 funding competitions are open! The Terry Fox Research Institute is pleased to announce the launch of its 2025 cancer research programs, funded by the Terry Fox Foundation.
TFRI News|March 25, 2024 The Terry Fox Research Institute and the Marathon of Hope Cancer Centres Network congratulate Dr. Lillian Siu on being elected president of the American Association for Cancer Research The Terry Fox Research Institute and the Marathon of Hope Cancer Centres Network congratulate Dr. Lillian Siu on being elected president of the Americ...
TFRI News|March 09, 2024 Honouring Dr. Connie Eaves: Stem Cell Pioneer Dr. Connie Eaves leaves a lasting legacy as an international leader in stem cell research, bone marrow transplantation and treatments for leukemia and...
TFRI News|February 14, 2024 Seven outstanding early-career researchers named 2024 Terry Fox New Investigators Seven talented, early-career scientists in Ontario, Quebec and British Columbia will each receive $450,000 over the next three years to support impact...
TFRI News|February 12, 2024 Celebrating International Day of Women and Girls in Science Meet Dr. Isabel Serrano, managing director of the Marathon of Hope Cancer Centres Network.
TFRI News|January 26, 2024 TFRI supports the next generation of cancer researchers in Canada The Terry Fox Research Institute has co-funded six Master’s and PhD students and one postdoctoral fellow as part of the Canadian Cancer Society’s inau...
TFRI News|January 25, 2024 TFRI announces new leadership appointment for Marathon of Hope Cancer Centres Network TFRI is pleased to announce that Dr. Isabel Serrano has been appointed to position of managing director of the Marathon of Hope Cancer Centres Network...
Research Highlight|December 14, 2023 Study finds new clinical trial drug boosts ability of oncolytic virus to target and kill cancer Researchers at The Ottawa Hospital have identified a method to boost the activity of cancer-fighting viruses by pairing one with a new cancer drug cur...
Research Highlight|December 14, 2023 BC team identifies drivers of aggressive childhood cancers and develops model to explore new treatments A team of BC-based researchers verified two drivers of cancerous tumours caused by DICER1 syndrome and developed an animal model that will allow them ...
Press Release|December 14, 2023 uOttawa research team reveals new insights into chemotherapy resistance With funding from a Terry Fox Program Project Grant, researchers at the University of Ottawa found that exposing cancer cells to sublethal doses of ch...
Research Highlight|December 14, 2023 Study finds smoking tobacco causes mutations that directly disable the genes protecting us from cancer Toronto-based researchers funded by The Terry Fox Research Institute have discovered one way smoking tobacco weakens the body’s natural defences and l...
Research Highlight|December 14, 2023 New findings reveal novel biomarker can predict success of immunotherapy A team of Montreal-based researchers discovered a novel biomarker that can help them predict which patients are most likely to benefit from immune che...
TFRI News|December 14, 2023 Dedicated cancer researchers raise more than $156k for research Terry Fox-funded researchers across Canada donned purple shirts for the 43rd annual Terry Fox Run in September and raised more than $156,000 for cance...
TFRI News|December 14, 2023 Canadian scientists John Bell and Linda Penn and former media executive Wendy Freeman appointed to TFRI’s Board of Directors TFRI recently welcomed three new members to its Board of Directors. Two are well known and leading Canadian cancer researchers who have also been fund...
Press Release|October 24, 2023 Blood test detects tumours early in families with cancer Researchers funded by The Terry Fox Research Institute have demonstrated that by analyzing patients’ blood samples, they are able to detect cancer ear...
TFRI News|August 17, 2023 Five new research teams named recipients of the 2023 Terry Fox New Frontiers Program Project Grants Five outstanding Canadian research teams will receive a total of $12 million to advance cancer research and treatment following new awards in the 2023...
TFRI News|August 17, 2023 We’re growing! Meet our newest team members We are pleased to welcome two new team members to our Vancouver office!
TFRI News|August 16, 2023 Register now for the 2023 Terry Fox Run! We hope you will consider registering for the run, fundraising for the Terry Fox Foundation and joining our annual Run Challenge. As Terry said back i...
Research Highlight|August 16, 2023 PROJECT UPDATE: Targeting metabolic vulnerabilities to improve cancer therapy A longstanding Terry Fox New Frontiers Program Project Grant team has come to understand that the process of cancer metabolism is not only central to ...
Research Highlight|August 16, 2023 In anticipation of the 2023 Terry Fox Run, Drs. Livia Garzia and Michael Monument discuss sarcoma research in Canada Funding from the Terry Fox Research Institute (TFRI) and the Marathon of Hope Cancer Centres Network (MOHCCN) is addressing research gaps to bring new...
Research Highlight|August 16, 2023 Researchers develop imaging method to study pancreatic cancers and their surrounding environment in real time A Toronto-based research team partially funded through a Terry Fox New Investigator Award to Dr. Ralph DaCosta has developed an innovative imaging pla...
Research Highlight|July 10, 2023 Terry Fox New Investigator finds that fecal transplants show promise in improving melanoma treatment In a first-of-its-kind Canadian clinical trial a group of researchers found that fecal microbiota transplants (FMT) are safe and show promise in impro...
Research Highlight|June 27, 2023 A Q&A with prostate cancer researcher Dr. Amina Zoubeidi TFRI reached out to prostate cancer researcher Dr. Amina Zoubeidi to learn more about her cancer research journey, the lessons she’s learned along the...
Research Highlight|June 22, 2023 Study reveals cause for different outcomes for patients that experience early and late relapse of diffuse large B-cell lymphoma A recent study sheds light on the cause behind the different outcomes of patients with diffuse large B cell lymphoma (DLBCL) who experienced a relapse...
Research Highlight|June 22, 2023 Une nouvelle étude révèle qu’un acide aminé pourrait servir au traitement de certains cancers agressifs Une étude conjointe menée sur trois ans par des scientifiques de l’Université McGill et de l’Université de Colombie-Britannique et financée en partie ...
Research Highlight|June 22, 2023 New study identifies amino acid to potentially treat aggressive cancers The dietary supplement alanine has been found to be effective in the treatment of aggressive cancers in preclinical models, such as small cell carcino...
Research Highlight|May 09, 2023 Novel strategy to penetrate cancer cell wall yields 25-fold increase in porphyrin uptake, improving photodynamic therapy and potential drug delivery TFRI-funded researchers have developed a novel strategy to penetrate the cancer cell wall yielding a 25-fold increase in porphyrin uptake, improving p...
Research Highlight|May 09, 2023 Scientists find Li-Fraumeni syndrome defined by more than one gene; expansion of genetic and epigenetic testing will benefit patients Scientists at The Hospital for Sick Children in Toronto find Li-Fraumeni syndrome may be defined by more than one gene, highlighting the benefits of e...
Research Highlight|May 09, 2023 Pan-Canadian multiple myeloma study recruits 95 patients, finds those resistant to immunotherapy show T-cell exhaustion signatures The pan-Canadian, TFRI-funded Multiple Myeloma Molecular Monitoring (M4) Study makes progress as researchers recruit 95 patients and find that those r...
Research Highlight|May 09, 2023 PROJECT UPDATE: A Q&A with Dr. Jeanette Boudreau, Halifax-based Terry Fox New Investigator, on harnessing the power of natural killer cells for immunotherapy in ovarian cancers We interviewed Dr. Jeanette Boudreau, a Halifax-based Terry Fox New Investigator who has identified a panel of markers that can be used to define natu...
Research Highlight|May 09, 2023 Study mimicking brain development identifies protein linked to neurodevelopmental disorders A TFRI-funded team based at the Princess Margaret Cancer Centre have identified a protein called RuvB-like 2 (RUVBL2) linked to certain rare neurodeve...
Research Highlight|May 09, 2023 Investigators explore how acute myeloid leukemia (AML) therapies can be tailored to individuals To better predict which acute myeloid leukemia (AML) therapy would be best suited for each patient, a team of researchers at Princess Margaret Cancer ...
TFRI News|May 09, 2023 TFRI is growing! Meet our newest team members and see who has taken on new roles We are pleased to welcome two new team members to our Vancouver office and announce a new role for a member of the TFRI communications team!
TFRI News|May 09, 2023 Terry Fox Run registration is open! Drs. Jim Woodgett and André Veillette share what research teams need to know Forty-three years after Terry's Marathon of Hope, his dream of ending cancer through research remains alive thanks to the incredible efforts of Canadi...
Press Release|February 06, 2023 Outstanding early-career researchers will receive just over $2 million after winning 2023 Terry Fox New Investigator Award The Terry Fox Research Institute has named five promising early-career researchers as the recipients of the 2023 Terry Fox New Investigator Awards.
Press Release|November 29, 2022 Five outstanding research teams share $22.4 million in funding of two new and three renewal Terry Fox New Frontiers Program Project Grants in 2022 competition Five Canadian cancer research teams will share $22.4 million to expand their research into key areas of cancer treatment after winning the 2022 Terry ...
Press Release|November 29, 2022 The Terry Fox Research Institute and the Canadian Institutes of Health Research co-fund new, prestigious grant to tackle high-risk breast cancer A new partnership between the Terry Fox Research Institute (TFRI) and the Canadian Institutes of Health Research (CIHR) will enable a team of multidis...
Press Release|November 29, 2022 L’Institut de recherche Terry Fox et les Instituts de recherche en santé du Canada cofinancent une prestigieuse nouvelle subvention visant à s’attaquer au cancer du sein à haut risque En vertu d’un nouveau partenariat créé entre l’Institut de recherche Terry Fox (IRTF) et les Instituts de recherche en santé du Canada (IRSC), une équ...
Research Highlight|November 26, 2022 TFRI BC Node Research Day: Winning posters We're happy to announce the winning posters of the BC Cancer Summit-TFRI BC Node Research Day.
TFRI News|November 08, 2022 TFRI's 9th Scientific Meeting brings cancer researchers from across Canada to Vancouver Over 230 delegates representing all our TFRI-funded projects were at the event, which featured scientific presentations from principal investigators a...
Press Release|October 19, 2022 The Terry Fox Research Institute Opens New Office in Montreal Based at the Montreal Clinical Research Institute, the new office and team will play an important role as TFRI ramps up its research capacity and cont...
TFRI News|October 19, 2022 Un bureau montréalais pour l'Institut de recherche Terry Fox Le nouveau bureau et la nouvelle équipe de l'Institut de recherche Terry Fox (IRTF), basés à l'Institut de recherches cliniques de Montréal (IRCM), su...
Research Highlight|October 14, 2022 Researchers discover how deadly brain cancer evades treatments While each patient's MRD profile was found to be unique, the team was able to see how these unique features affected the trajectory to their cancer re...
TFRI News|October 05, 2022 Researchers break fundraising record, raise nearly $197k for research Scientists and clinicians funded by the TFRI showed up in full force for this year’s Terry Fox Run, raising over $123,000 for cancer research.
TFRI News|August 29, 2022 Support the 2022 Terry Fox Run Challenge The following teams have registered for this year's challenge. You can click on the link next to the team to donate to their run.
TFRI News|July 05, 2022 Launching the 2022 Terry Fox Run Challenge: A letter from Dr. Jim Woodgett The 2022 Terry Fox Run will take place on Sunday, Sept 18th, and it is my pleasure to invite you once again to register for the run and participate in...
Research Highlight|June 03, 2022 New clinical trial in dogs seeks to test innovative “seek and destroy” treatment that could bring new hope to pets and people with cancer A nanoparticle developed by TFRI-funded researchers is being used for the first time as part of an innovative clinical trial in dogs that could pave t...
TFRI News|May 06, 2022 Save the date: Upcoming TFRI events TFRI is pleased to provide this list of upcoming events offered and supported in 2021-2022. Visit the links provided for full details and to register.
News|May 06, 2022 TFRI News: Meet our newest team members A number of new employees have joined the Terry Fox Research Institute over the last few months. Here, we present our newest team members!
Research Highlight|May 06, 2022 Re-defining Li-Fraumeni Syndrome: A catchup with Dr. David Malkin, leader of the Terry Fox New Frontiers Program Project Team studying Li-Fraumeni Syndrome Over the last four years, the team has made significant findings that better help understand, diagnose, and potentially treat this cancer predispositi...
Research Highlight|May 06, 2022 Study identifies gaps in measuring symptom burden in Ontario adolescents and young adults with cancer A study by a Terry Fox New Investigator has revealed gaps in the provincial program designed to measure these symptoms in cancer patients.
Research Highlight|April 06, 2022 New study finds that location of immune cells is critical for immunotherapy response An innovative new approach highlights the relevance of immune cells’ position within melanoma to inform on a patients’ response to immune therapy.
TFRI News|February 16, 2022 L'Institut de recherche Terry Fox annonce la nomination du Dr André Veillette au poste de directeur exécutif du Réseau des centres d’oncologie du Marathon de l'espoir L'Institut de recherche Terry Fox (IRTF) a le plaisir d'annoncer la nomination d'un éminent médecin et scientifique canadien, le Dr André Veillette, a...
Press Release|February 16, 2022 The Terry Fox Research Institute announces Dr. André Veillette as new Executive Director for the Marathon of Hope Cancer Centres Network The Terry Fox Research Institute (TFRI) is pleased to announce the appointment of prominent Canadian physician-scientist, Dr. André Veillette, to the ...
Research Highlight|February 10, 2022 Gut bacteria linked to immune suppression in pancreatic cancer: Study Lactobacillus – a type of bacteria thought to promote gut health – can alter the function of immune cells called macrophages in the pancreatic tumour ...
TFRI News|February 03, 2022 Outstanding early-career researchers will receive $1.8 million after winning 2022 Terry Fox New Investigator Award Four promising, early-career scientists in Montreal, Toronto and Vancouver will each receive $450,000 over the next three years to support groundbreak...
Research Highlight|November 15, 2021 New prognostic biomarkers and cancer-driving genes found in the dark matter of the cancer genome Catalogue of 166 biomarkers generated through machine learning analysis of long non-coding RNAs
Research Highlight|November 01, 2021 TFRI hosts talk on the future of clinical trials featuring Dr. Elizabeth Eisenhauer Last Friday, October 29th, the TFRI hosted a virtual talk with Dr. Elizabeth Eisenhauer, professor emerita, oncology and medicine, Queen's University,...
Research Highlight|November 01, 2021 Lymphoma PPG team presents updates during first event of TFRI's Pan-Can Seminar Series Members of TFRI's BC-based Terry Fox New Frontiers Program Project Grant in Overcoming treatment failure in lymphoid cancers presented during the firs...
Research Highlight|November 01, 2021 EPPIC Researchers present in first Marathon of Hope Cancer Centres Network Seminar Series Researchers from TFRI's Enhanced Pancreatic Cancer Profiling for Individualized Care presented during the first event of the Marathon of Hope Cancer C...
TFRI News|October 25, 2021 Save the date: Upcoming events TFRI is pleased to provide this list of upcoming events offered and supported in 2021-2022. Visit the links provided for full details and to register.
TFRI News|October 22, 2021 Terry Fox Run Challenge: Researchers break fundraising record, raise nearly $125k for research Scientists and clinicians funded by the TFRI showed up in full force for this year’s Terry Fox Run, raising over $123,000 for cancer research.
Research Highlight|October 21, 2021 Study reveals a new target that suggests leukemia in children with Down syndrome could be prevented TFRI-funded researchers in Toronto have uncovered new information on the intricate relationship between the extra copy of chromosome 21 and leukemia, ...
Research Highlight|October 21, 2021 New study shows that exposure to ambient air pollution is a significant contributor to lung cancer among non-smokers Researchers from TFRI’s Pan-Can Lung Study team have pinpointed why more non-smokers are developing lung cancer, providing the basis for creating stra...
Research Highlight|October 21, 2021 TFRI-funded biobank used to make important findings that could help personalize and improve treatments for ovarian cancers Twelve years after it first received TFRI funding, the resource continues to be invaluable for researchers.
Research Highlight|October 21, 2021 New study reveals the genes that drive cancer in a subset of patients with medulloblastoma A new international study led by researchers partly funded by the TFRI has uncovered a number of genes that drive cancer in a subset of patients with ...
Research Highlight|October 21, 2021 Lymphoma team publishes two papers on diffuse large B-cell lymphoma in major journal Both papers help to better understand diffuse large B-cell lymphoma (DLBCL), a heterogeneous form of non-Hodgkin lymphoma that has an average five-yea...
Research Highlight|October 21, 2021 Study identifies that all cancers can be classified into two groups based on presence of YAP protein: Q&A with Dr. Rod Bremner A group of researchers partly funded by the TFRI has found that all cancers can be classified into two distinct groups based on the presence of a prot...
Research Highlight|October 21, 2021 RNA-seq is the best available tool to personalize treatment for patients with acute myeloid leukemia, study finds TFRI-funded researchers at BC Cancer in a new study demonstrate that a genomic test known as whole transcriptome sequencing (RNA-seq) is the best avai...
Research Highlight|September 10, 2021 New study helps understand who will benefit from immunotherapy TFRI-funded researchers at the Princess Margaret Cancer Centre in Toronto have made findings which help expand understanding of which patients will be...
TFRI News|August 30, 2021 TFRI launches 2021 Terry Fox Run Challenge The Terry Fox Research Institute (TFRI) is happy to launch its 2021 Terry Fox Run Challenge, an annual event in which our research teams look to claim...
TFRI News|August 19, 2021 The TFRI launches open call for white papers for the Marathon of Hope Cancer Centres Network The Terry Fox Research Institute (TFRI) is pleased to announce a first call for White Papers for the Marathon of Hope Cancer Centres Network (MOH...
Press Release|August 12, 2021 Les chercheurs de l’Atlantique unissent leurs forces et reçoivent 3,6 millions de dollars de nouveaux fonds provinciaux et nationaux pour accélérer la médecine de précision pour les patients atteints de cancer Pendant deux ans, le groupe collaborera dans un projet pilote commun dans le but de devenir membre à part entière du Réseau des centres d’oncologie du...
Press Release|August 12, 2021 Atlantic researchers join forces, receive $3.6 million in new provincial and national funding to accelerate precision medicine for cancer patients The group will work together under a joint pilot project over two years with the goal of becoming a full partner in the Terry Fox Research Institute’s...
Press Release|July 21, 2021 Distinguished Toronto Scientist Dr. Jim Woodgett Takes Up Leadership of Terry Fox Research Institute on August 1 The Board of Directors of the Terry Fox Research Institute (TFRI) announces the appointment of Jim Woodgett, a senior scientist based at the Lunenfeld...
Research Highlight|June 11, 2021 Oncolytic viruses could provide a precision medicine alternative for some hard-to-treat melanomas A subset of ICI-resistant melanoma patients who display mutations in a specific pathway known as the interferon (IFN)γ-JAK-STAT pathway could benefit ...
Research Highlight|June 08, 2021 Study identifies biomarkers that predict which pancreatic cancer patients with germline BRCA mutations will benefit from personalized therapies using platinums and PARP inhibitors A new study published in Clinical Cancer Research (October 2020) provides insight into which pancreatic cancer patients with germline BRCA mutations w...
Research Highlight|May 27, 2021 Could wearable technology help detect deadly brain cancers early on? Ontario-based researchers led by Terry Fox New Investigator Dr. Phedias Diamandis are researching the possibility of harnessing the power of brain wea...
Research Highlight|May 27, 2021 Study reveals correlation between self-reported symptom burden and hospital visits in patients with Head and Neck Cancers Findings published in the Journal of Clinical Oncology provide the first evidence that tools currently used by patients to report symptoms could be an...
Research Highlight|May 27, 2021 New approach allows researchers to explore areas surrounding tumours to find signatures associated with prostate cancer progression Ontario-based researchers led by Dr. Hansen Housheng He have used single-cell RNA-sequencing to analyze the tumour microenvironment, helping them iden...
Research Highlight|May 27, 2021 Study reveals key genetic mutation that leads to the development of aggressive pediatric brain tumour A study by a Quebec-based team that includes several TFRI-funded researchers has found that many patients with a subtype of gliomas known as G34R/V hi...
Research Highlight|May 26, 2021 New finding sets the stage for clinical trial to better manage cancers that metastasize to the brain TFRI-funded researchers in Montreal have discovered how cancers that metastasize to the brain are able to invade distantly into the surrounding tissue...
TFRI News|May 26, 2021 Le Réseau des centres d’oncologie du Marathon de l’espoir donne un coup d’accélérateur à son plan relatif à la médecine de précision en signant un accord de contribution avec Santé Canada Le gouvernement du Canada et l’Institut de recherche Terry Fox (IRTF) ont signé un accord de contribution qui pave la voie au Réseau des centres d’onc...
Press Release|May 26, 2021 Marathon of Hope Cancer Centres Network accelerates precision medicine plan with signing of Contribution Agreement with Health Canada The Government of Canada and the Terry Fox Research Institute (TFRI) have jointly signed a Contribution Agreement which opens the door for the Maratho...
TFRI News|March 25, 2021 New Chief Financial Officer for TFRI will help steward new precision medicine projects and longstanding peer-review programs Gordon Schwark will apply his deep understanding of research, academia, funder reporting requirements, and charitable organizations in this new role a...
TFRI News|March 24, 2021 Key leadership hired for new Digital Health and Discovery Platform (DHDP) led by TFRI and main partner Imagia The Terry Fox Research Institute (TFRI) is pleased to announce the appointment of two key leadership personnel to develop, implement and manage the ne...
TFRI News|March 24, 2021 Passionate Terry Foxer with proven track record for executing vision is eager to lead new precision medicine and AI platform Pickard has extensive experience in business planning, operations, contracts, intellectual property, and commercialization, as well as in health data ...
TFRI News|March 24, 2021 Seasoned data expert passionate about using data and digital assets to improve the health care system and provide the best patient care Shari Dworkin is Chief Data Officer for TFRI’s Digital Health and Discovery Network. A strategic leader, data expert and innovator, Dworkin has 20 yea...
TFRI News|March 23, 2021 What Terry Fox and His Legacy Means to Me By Bryce Pickard, Executive Director, Digital Health and Discovery Program Like many worldwide, I grew up hearing the story of Terry Fox, a story syno...
TFRI News|March 10, 2021 Terry Fox Foundation Appoints New Executive Director The Terry Fox Foundation’s Board of Directors is pleased to announce the appointment of Michael Mazza as Executive Director, effective March 1, 2021. ...
Research Highlight|March 01, 2021 Turbocharging the killing power of immune cells against cancer Creating “super soldiers” of specific white blood cells to boost an anti-tumour response has been shown in a series of elegant experiments by TFRI-fun...
Research Highlight|January 08, 2021 Cancer cells hibernate like bears to evade harsh chemotherapy A team led by Dr. Catherine O’Brien, a TFRI-funded scientist at the Princess Margaret Cancer Centre in Toronto, discovered that when under threat, all...
Research Highlight|December 14, 2020 Administering low-dose chemotherapy improves cancer vaccine’s effectiveness in mice models TFRI-funded researchers from the Canadian Oncolytic Virus Consortium (COVCo) have found a way to improve the efficacy of therapeutic cancer vaccines, ...
Press Release|December 14, 2020 Dedicated Terry Foxer and government relations expert Carolyn Chisholm joins TFRI’s Board of Directors The Terry Fox Research Institute is pleased to announce that Carolyn Chisholm, a long-time Terry Fox supporter and an expert in federal and provincial...
Research Highlight|December 14, 2020 Study reveals unique mutational pattern in patients with early-onset pancreatic cancer TFRI-funded researchers have found that patients with early-onset pancreatic cancer have a distinct mutational pattern in a gene called CDKN2A. This d...
Research Highlight|December 14, 2020 New study reveals why some patients with myelodysplastic syndrome become resistant to treatment BC-based researchers led by Drs. Aly Karsan and Sergio Martinez-Høyer have found that mutations in two genes – TP53 and RUNX1 – are responsible for dr...
Research Highlight|December 10, 2020 Two New Frontiers Program Project Grant teams receive $10.9 million for research excellence, expansion to new key areas Two outstanding teams in Ontario will receive $10.9 million over the next six years to advance research into key areas of cancer development after bei...
Research Highlight|December 09, 2020 Lung study team’s findings on early detection translate into first lung cancer screening program in Canada It is a blessing to be able to see the Terry Fox Research Institute translational research program involving eight centres across Canada come to fruit...
Research Highlight|December 08, 2020 Team turns to machine learning to predict patient response to therapy, accelerate precision medicine Dr. Gregory Czarnota and his Terry Fox team are amongst a number of pioneering researchers using machine learning to analyze images of tumours. In doi...
Research Highlight|December 08, 2020 Why does sex affect cancer? New study reveals oncogenomic differences between males and females A new study led by former Terry Fox New Investigator Dr. Paul Boutros reveals key differences in specific genes and in genome-wide phenomena that may ...
Research Highlight|December 08, 2020 Study reveals key genetic mutation that leads to the development of aggressive bone tumour Quebec-based researchers partly funded by the TFRI have discovered that a single mutation in a gene called Histone 3.3 is responsible for the developm...
TFRI News|December 02, 2020 Appointment to Order of Canada recognizes contributions to lymphoid cancer by former TFRI-funded researcher Dr. Joseph Connors A former researcher and oncologist at BC Cancer has been appointed as a Member of the Order of Canada for his outstanding contributions to the field o...
Research Highlight|November 30, 2020 Mapping out the mystery of blood stem cells Using state-of-the art sequencing technology, Princess Margaret scientists have revealed how stem cells are able to generate new blood cells throughou...
TFRI News|November 05, 2020 2020 Terry Fox Run Challenge: Researchers show up virtually and raise nearly $98k for cancer research TFRI-funded researchers showed up in full force for the 40th annual Terry Fox Run, raising a whopping $97,934 for cancer research.
Research Highlight|October 22, 2020 Calgary-based researchers discover new tactic that could help stop the growth of a deadly brain cancer The finding, published in Nature Communications, provides a new tactic in the war against cancer that involves reprogramming the immune system to do w...
Research Highlight|September 01, 2020 New study reveals mechanisms that drive chemotherapy resistance in aggressive breast cancers Targeting breast cancer cells that change and adapt to evade chemotherapy in order to survive and grow, could be a new way to treat the often deadly t...
Research Highlight|September 01, 2020 Developing precision medicine alternatives for triple negative breast cancer TFRI-funded scientists in Toronto have made a discovery that could unlock precision medicine treatments for patients diagnosed with triple negative br...
Research Highlight|August 31, 2020 New treatment possibilities for young women diagnosed with rare form of ovarian cancer A recent finding by TFRI-funded researchers in BC may offer a new treatment possibility for people diagnosed with a rare and aggressive form of ovaria...
Research Highlight|August 31, 2020 Repurposing cholesterol drugs to treat multiple myeloma A new study TFRI-funded researchers at Princess Margaret Cancer Centre found that drugs prescribed to lower blood cholesterol, known as statins, may b...
TFRI News|August 17, 2020 Marathon of Hope Cancer Centres Network operational plan continues to take shape Plans for implementation of the new pan-Canadian network to accelerate precision medicine continue to move ahead with partners and leaders from the fo...
Research Highlight|August 17, 2020 Quantifying PTEN loss could help stratify risk of relapse for patients with prostate cancer, study finds A research team in Kingston, Ontario has identified the specific threshold at which PTEN loss becomes clinically significant, presenting a new tool th...
TFRI News|August 17, 2020 Terry Fox Run 2020: Important information for researchers For the first time ever, the 2020 Terry Fox Run will be held virtually. This year’s theme, One Day, Your Way! encourages participants to be creative w...
Press Release|August 12, 2020 Medical oncologist Dr. Tony Reiman joins TFRI Executive as new Atlantic Node Leader The Terry Fox Research Institute (TFRI) is pleased to announce the appointment of Dr. Tony Reiman as its Atlantic Node Leader, representing the provin...
Research Highlight|August 05, 2020 Alberta-based brain researcher team publishes papers in two high-impact journals Members of a translational research project supported by TFRI from 2012 to 2019 continue to make an impact with two recent publications in important m...
Research Highlight|August 05, 2020 Study finds that nanobubbles can exit vascular system, bringing ultrasound-based therapies one step closer to reality Researchers have devised a method to get nanobubbles out of the vascular system intact, presenting a means by which to access and treat deep-seated tu...
Research Highlight|August 05, 2020 Researchers identify mutation associated with improved survival in Diffuse Large B-cell Lymphoma BC-based researchers have found that TMEM30A loss affects the cell membrane, allowing drugs to be delivered into cancer cells more effectively and imp...
Research Highlight|August 05, 2020 New immunotherapy shows promise in treating aggressive adult brain cancer A new CAR-T cell therapy developed by researchers in Hamilton and Toronto may help treat glioblastoma (GBM), an aggressive form of brain cancer that a...
Research Highlight|August 04, 2020 A blood test could predict who benefits from immunotherapy A test which detects changing levels of tumour fragments in the blood may be an easy, non-invasive and quick way to predict who will benefit from immu...
Research Highlight|June 23, 2020 Montreal Cancer Consortium team sheds light on why men may be genetically more prone to melanoma A new study by researchers from the Montreal Cancer Consortium is shedding new light on the role sex genes play in melanoma progression, providing new...
TFRI News|June 19, 2020 TFRI launches 2020 Terry Fox Run Challenge The Terry Fox Research Institute (TFRI) has launched its 2020 Terry Fox Run Challenge, an annual event in which our research teams look to claim top h...
TFRI News|May 28, 2020 TFRI update on COVID-19 and cancer research funding Most cancer research across Canada is curtailed due to the COVID-19 health emergency. Like other philanthropic organizations, our funding for cancer r...
Research Highlight|May 27, 2020 Team isolates rare clones destined to cause relapse within diagnosis samples of acute lymphoblastic leukemia Diagnosis relapse initiating (dRI) clones have unique characteristics that favor relapse and can be found in diagnosis samples from patients, meaning ...
Press Release|May 27, 2020 Clinical trial reveals more effective way to treat aggressive prostate cancers A clinical trial led by BC-based researchers partly funded by the TFRI has revealed that administering abiraterone acetate first, with enzalutamide af...
Research Highlight|May 27, 2020 Promising new antigens found in non-coding ovarian cancer DNA may provide clues for therapeutic vaccine Ovarian cancer researchers in Montreal are hoping newly found molecules might be used to create vaccines for patients with an aggressive form of the d...
Research Highlight|May 27, 2020 New study suggests MRI images can predict how patients with brain metastasis will respond to radiotherapy Quantitative biomarkers derived from conventional MRI in conjunction with machine learning techniques can, potentially, be used to predict outcomes fo...
Research Highlight|May 25, 2020 New study reveals genetic "scars" caused by cancer therapy A new study led by two BC-based researchers affiliated with TFRI and the Marathon of Hope Cancer Centres Network has revealed the genetic "scars" caus...
Research Highlight|May 19, 2020 Researchers identify how hormones and aging affect breast cancer in largest study of its kind After reviewing over 7,000 cancer tissues, researchers partly funded by the TFRI are shedding new light on the relationship between age-related change...
Research Highlight|May 19, 2020 Scientists identify promising immunotherapy combination for pediatric brain cancer An international team that includes TFRI-funded researchers has discovered that combining immunotherapy with a drug called tumor necrosis factor (TNF)...
Research Highlight|April 20, 2020 Pancreatic cancer researchers encouraged by new T-cell finding that identifies patients with hallmarks of an antitumour response A small subset of patients with pancreatic cancer exhibit a T-cell inflamed profile, a finding that could open the door for the potential use of immun...
TFRI News|March 25, 2020 Update on TFRI activities during pandemic We have postponed a number of important meetings such as our 9th Scientific Meeting, and the peer review meetings for our current PPG competition. TFR...
Press Release|February 18, 2020 L’Institut de recherche Terry Fox et les Instituts de recherche en santé du Canada investissent ensemble deux millions de dollars pour soutenir les travaux de nouveaux chercheurs prometteurs Cinq chercheurs de Toronto amorçant une carrière prometteuse dans le domaine du cancer recevront un total de deux millions de dollars pour mener des t...
TFRI News|February 18, 2020 The Terry Fox Research Institute and the Canadian Institutes of Health Research partner to invest $2-million to support research of promising new investigators Five promising, Toronto-based, early career cancer researchers will receive a total of $2-million to undertake research on a deadly brain cancer calle...
TFRI News|January 16, 2020 From the President’s Desk: An update on the Marathon of Hope Cancer Centres Network Dr. Victor Ling provides on update on the Marathon of Hope Cancer Centres Network and discusses what 2020 will bring for the Terry Fox Research Instit...
Research Highlight|January 15, 2020 Lung study team optimistic about new algorithm that can detect lung cancer up to three years before it forms TFRI’s Early Detection Lung Study has developed a way to help doctors predict who is at higher risk of developing the disease.
Research Highlight|January 15, 2020 Targeting the CXCL12/CXCR4 pathway could make curative radio-chemotherapy more effective, less toxic for patients with cervical cancer A groundbreaking discovery by a group of TFRI-funded scientists in Toronto is paving the way for the creation of combination therapies that could make...
Research Highlight|January 15, 2020 Goundbreaking discovery could help block metastasis for two kinds of sarcomas, including the one that claimed Terry Fox TFRI researchers have found that a family of drugs known as Class 1 HDAC inhibitors can block sarcoma metastasis in mice by hindering a cancer cell’s ...
Research Highlight|January 15, 2020 New resource could help researchers use genomic information to determine how a patient will respond to radiation therapy A new computational resource by a group of TFRI-funded researchers in Toronto may one day provide some answers about how patients respond to radiation...
Research Highlight|January 14, 2020 TFRI-funded researchers in Toronto turn 'junk' DNA into gold Mining the rich, uncharted territory of the genome or genetic material of a cancer cell has yielded gold for TFRI-funded scientists at the Princess Ma...
Research Highlight|January 14, 2020 New discovery reveals how Hodgkin lymphoma avoids attack from immune cells A team of lymphoma researchers partly funded by the TFRI has discovered a unique way in which Hodgkin lymphoma cells interact with regular immune cell...
Press Release|January 14, 2020 New member Carol Chiang brings wealth of financial experience to TFRI’s Board of Directors The Terry Fox Research Institute (TFRI) is pleased to announce that Vancouver financial leader Carol Chiang has joined its Board of Directors as a mem...
Research Highlight|January 14, 2020 Toronto-based clinical trial reveals new subtypes of advanced pancreatic cancer Toronto-based researchers partly funded by the TFRI have discovered detailed new information about the subtypes of pancreatic cancer.
Research Highlight|January 09, 2020 Virus associated with hand, foot and mouth disease helps fight lung adenocarcinomas in mice TFRI researchers have identified that Coxsackievirus Type B3, a virus commonly associated with hand, foot and mouth disease in children, can significa...
Research Highlight|January 09, 2020 Newly created synthetic cancer cells help advance understanding of leukemias For the first time ever, a team of TFRI-funded researchers has created synthetic cancer cells that are indistinguishable from T-cell acute lymphoblast...
Research Highlight|January 09, 2020 Study provides new insights on how aggressive breast cancer cells get the energy they need to grow A new study reveals how HER2-positive breast cancer hijack metabolic pathways to produce the extra energy they need to grow and spread.
Research Highlight|January 09, 2020 Team identifies four subtypes for common form of pancreatic cancer based on metabolic pathway alterations A team of Terry Fox-funded researchers has revealed that genetic alterations affecting the metabolic pathways of cancer cells drive outcomes in patien...
Research Highlight|October 16, 2019 TFRI-team creates first-of-its-kind proteogenomic resource for prostate cancer, providing key insights into the biology of tumours The resource combines genomic, epigenomic, transcriptomic and proteomic data from localized, intermediate-risk prostate cancers and sheds light on the...
Research Highlight|October 16, 2019 New finding sheds light on neuroendocrine prostate cancer progression New study reveals how RNA splicing of BHC80 promotes the development of treatment-induced neuroendocrine prostate cancer, providing potential avenue f...
Research Highlight|October 16, 2019 How this TFRI-funded team is finding inspiration in nature and harnessing the power of light to improve cancer care Eight years ago, researchers looking to improve how cancer is diagnosed and treated decided to develop a nanoparticle that mimicked how natural organi...
TFRI News|October 16, 2019 An Update from our President TFRI President and Scientific Director, Dr. Victor Ling, provides an update on how we're progressing in our efforts to make the Marathon of Hope Cance...
TFRI News|October 16, 2019 New TFRI poster and presentation templates for researchers The TFRI poster and presentation templates for researchers reflect our organization's refreshed brand identity.
TFRI News|October 15, 2019 TFRI will host special session on Marathon of Hope Cancer Centres Network at 5th CCRC meeting On Monday, November 4 we will host a special 30-minute presentation on the Marathon of Hope Cancer Centres Network.
Research Highlight|October 04, 2019 Early results from two studies provide insight into who may benefit from immunotherapies Two recent studies partly funded by the TFRI are showing results that provide key insights into how immunotherapy works, and who may benefit from it.
Research Highlight|October 04, 2019 Pan-Canadian team identifies two biomarkers that predict prostate cancer aggressiveness and bone metastasis The discoveries that the proteins p65 and CCN3 indicate cancer aggressiveness could help bridge a major gap that still exists in prostate cancer resea...
Research Highlight|October 04, 2019 Toronto-based team identifies potential target to supress leukemia stem cells Targeting a gene called INKA1 may supress leukemia stem cells (LSCs), stopping the disease in its tracks or preventing relapse in patients who have al...
Research Highlight|October 04, 2019 Collaborators identify new anti-tumour target TP73/p73 with potential to attack cancer stem-like cells and help avoid cancer relapse New discovery provides key insights into the mechanisms used by cancer cells to elude treatment and finds a new target that could be exploited to disr...
Research Highlight|October 04, 2019 Artificial intelligence helps researchers predict if breast cancer patients will respond to chemotherapy before treatment is administered A team of TFRI-funded researchers based out of the Sunnybrook Research Institute in Toronto has devised a new technique that could determine if patien...
TFRI News|October 02, 2019 Terry Fox PROFYLE research shows profiling cancer tumours in real time is giving hope to children and young adults previously out of treatment options Early results show that an innovative research program honouring Terry Fox’s legacy is providing treatment opportunities to children and young adults ...
TFRI News|September 30, 2019 2019 Terry Fox Run Challenge: TFRI research teams show immense support, raise over $80k for research TFRI-funded researchers showed up in full force for the 39th annual Terry Fox Run, adding a splash of purple to run sites across the country and raisi...
Event|August 02, 2019 Mark your Calendars: TFRI Ontario Node will host annual Research Symposium on Dec. 12, 2019 The Terry Fox Research Institute's Ontario Node is happy to announce that it will be holding its annual Research Symposium on Thursday, Dec. 12 at the...
TFRI News|July 26, 2019 TFRI Launches 2019 Terry Fox Run Challenge the TFRI is proud to launch the 2019 Terry Fox Run Challenge. Our goal for this year is to surpass the amount of money raised in 2018.
Press Release|July 11, 2019 TFRI and partners react to investment of $150M by Federal Minister of Health to create “Team Canada of Cancer Research” The federal Minister of Health, Ginette Petitpas Taylor, announced today an investment of $150 million over five years by the Government of Canada for...
Press Release|July 11, 2019 Federal Minister of Health shows government support for Marathon of Hope Cancer Centres network through $150-million investment to accelerate precision medicine The federal Minister of Health, Ginette Petitpas Taylor, announced today an investment of $150 million over five years by the Government of Canada to ...
Press Release|July 04, 2019 Two top Canadian research teams receive $12 million to solve key cancer challenges The teams, which are based in Toronto and Montreal/Ottawa, will use the funding to dive deep into the unique biology of cancer cells with the hopes of...
Press Release|July 03, 2019 Trouver dans le microenvironnement des tumeurs de nouvelles cibles thérapeutiques en vue de personnaliser les traitements contre le cancer Une équipe de spécialistes chevronnés du Princess Margaret Cancer Centre de Toronto est appelée à élargir ses travaux de recherche novateurs sur les e...
Press Release|July 02, 2019 L’Institut de recherche Terry Fox et la Fondation du cancer du sein du Québec s’unissent pour financer à hauteur de 6 M$ une équipe de chercheurs explorant de nouvelles façons de traiter le cancer du sein métastatique Grâce à un nouveau financement de six millions de dollars sur une période de six ans, une équipe de chercheurs basée à Montréal et à Ottawa tentera de...
Research Highlight|June 14, 2019 A "one-two punch" to wipe out cancerous ovarian cells A team of researchers led by former Terry Fox New Investigator Francis Rodier (University of Montreal Hospital Research Centre - CRCHUM) has developed...
Research Highlight|June 03, 2019 New finding may aid in prediction of aggressiveness of colorectal cancer The deletion of Interleukin-17 receptor (IL-17R), a receptor gene that regulates inflammation, may help predict the aggressiveness of colorectal cance...
Research Highlight|June 03, 2019 Spatial organization of immune cells within tumour microenvironment tied to survival of lung cancer patients “The main concept we wanted to demonstrate is that the spatial organization of immune and tumour cells has a clinical impact. In other words, it’s not...
Research Highlight|June 03, 2019 EZH2 inhibitors could make immunotherapies more effective for a subset of patients with diffuse large B-cell lymphoma A study by a group of BC-based scientists partly funded by the TFRI has discovered mutations responsible for changes in expression of major histocompa...
Research Highlight|June 03, 2019 New research suggests immunotherapy could help nearly 50 per cent of patients with rare mesothelioma A team of scientists partly funded by the Terry Fox Research Institute has shown that nearly half of all patients with peritoneal mesothelioma (PeM), ...
TFRI News|June 03, 2019 Update on the Marathon of Hope Cancer Centres Network There have been a number of activities under way since the Government of Canada’s announcement in March 2019 that it would provide up to $150 million ...
Research Highlight|June 03, 2019 Scientists find common brain cancer found in childhood is related to early brain development A new study on the origin and development of pediatric tumours of the cerebellum, such as medulloblastoma, has concluded that these tumours are a diso...
TFRI News|May 27, 2019 TFRI refreshes its visual identity with new logo and website The Terry Fox Research Institute is proud to announce the adoption of a brand-new visual identity as it enters its second decade of research.
TFRI News|May 27, 2019 Dr. Marla Shapiro joins TFRI Board of Directors The Terry Fox Research Institute is pleased to announce the appointment of Dr. Marla Shapiro to its board of directors.
TFRI News|May 24, 2019 Federal Government Awards $49M to Terry Fox Research Institute and Imagia led Consortium to Accelerate Medical Breakthroughs The new Digital Health and Discover Platform will greatly empower the Marathon of Hope Cancer Centres network, launched by the Terry Fox Research Inst...
Press Release|May 23, 2019 Minister Bains announces investment to accelerate medical breakthroughs that will enable truly personalized health care Today the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development, announced an investment of up to $49 million in the Digi...
Research Highlight|May 15, 2019 Team identifies new classification system for Burkitt’s Lymphoma and opens door for more precise treatments A group of scientists partly funded by the Terry Fox Research Institute has discovered a better way to classify Burkitt’s lymphoma (BL), a rare type o...
Research Highlight|May 15, 2019 Terry Fox New Investigator publishes two major papers in top scientific journals In the span of just a couple of months, TFRI New Investigator Dr. Housheng Hansen He has had major papers published in Cell and Nature Communications,...
Research Highlight|May 14, 2019 TFRI-funded scientists publish snapshot on oncolytic viruses in top scientific journal Members of a long-standing TFRI team focused on developing cancer-killing viruses have published a snapshot article summarizing this promising area of...
Research Highlight|May 14, 2019 Promising findings in pancreatic cancer study highlight the importance of genetic sequencing A study by researchers from TFRI’s Enhanced Pancreatic Cancer Profiling for Individualized Care (EPPIC) research program has led to the discovery of a...
In the Media|April 15, 2019 Media coverage across Canada highlights historic launch of the Marathon of Hope Cancer Centres Media outlets across Canada highlighted the historic launch of the Marathon of Hope Cancer Centres that took place last Friday, April 12th in St. John...
Press Release|April 11, 2019 Inspired by Terry Fox's legacy, Canadian cancer centres join forces for the first time Inspired by the legacy of Terry Fox, today the Terry Fox Research Institute and partners launched a new national network to bring together, for the fi...
Press Release|April 11, 2019 Cancer centres and researchers in Atlantic Canada join forces to provide precision medicine for cancer patients across region For the first time, leading cancer centres, hospitals and researchers in Atlantic Canada are coming together to help deliver personalized and precisio...
TFRI News|April 05, 2019 Media Advisory and Statement Regarding the Marathon of Hope Cancer Centres Network The official launch of the Marathon of Hope Cancer Centres Network will take place on Friday, April 12th in St. John's, N.L., on the same date and pla...
TFRI News|March 20, 2019 Response to the Federal Government's budget announcement regarding $150M for the Marathon of Hope Cancer Centres Network “We are thrilled with today’s announcement by the federal government to support the creation of the Marathon of Hope Cancer Centres. Under this new Te...
In the Media|March 20, 2019 Terry Fox research gets $150m for cancer data network The federal Liberals awarded $150 million to the Terry Fox Research Institute Tuesday, to create an online program for researchers to share cancer inf...
Research Highlight|February 25, 2019 Blocking Type 1 Interferon reduces negative side-effects associated with potent immunotherapy A group of scientists from the TFRI-funded Canadian Oncolytic Virus Consortium (COVCo) has discovered a new way to reduce negative side-effects associ...
In the Media|January 21, 2019 U of A oncology doctor to represent province on Terry Fox Research Institute executive When Dr. David Eisenstat decided to organize a camp charity run in the summer of 1981 inspired by the courageous cancer battle fought by Terry Fox, he...
Research Highlight|January 15, 2019 Use of mTOR inhibitors increases efficacy of herpes virus as an oncolytic therapy A new study by a team of TFRI-funded scientists has found that combining a particular strain of the herpes virus with mTOR inhibitors improves viral r...
Research Highlight|January 15, 2019 Montreal research team identifies SREBF1 as a new, targetable regulatory pathway in prostate cancer The newly discovered pathway, SREBF1, was found to be directly responsible for controlling prostate cancer cell metabolism. It can be targeted with se...
Research Highlight|January 15, 2019 Study reveals genomic differences between long- and short- term survivors of high-grade serous ovarian cancer, advancing potential for individualized treatments Researchers may be one step closer to personalizing treatments for patients with high-grade serous ovarian cancer thanks to a new study that revealed ...
Research Highlight|January 15, 2019 New finding suggests that disrupting interaction between MYC and G9a could stop cancer growth New technology has helped a TFRI-funded multidisciplinary research team identify how MYC – a key driver of human cancer – works, cracking open the pos...
Research Highlight|January 15, 2019 Pan-Canadian prostate cancer team creates robust resource tool to help clinicians with treatment decision-making A pan-Canadian prostate cancer group funded by the TFRI team has created a new tissue microarray (TMA)-based resource to assist clinicians and patholo...
Research Highlight|January 15, 2019 CEST MRI may be able to measure patient response to chemotherapy within 24 hours after first dosage TFRI researchers at Sunnybrook Hospital have found that CEST MRI technology can be used to detect cancer cell death in mice within 24 hours of receivi...
Research Highlight|January 15, 2019 Restoring stem cells to a fetal-like state could provide a therapeutic alternative for acute leukemias A team of TFRI-funded scientists in Vancouver has discovered that restoring a signaling pathway that is prevalent in fetal stem cells but dormant in a...
Research Highlight|January 15, 2019 Study shows benefit of vascular normalization in OV therapy for advanced epithelial ovarian cancer Immunologists at the University of Guelph have discovered that normalizing blood flow into tumours improves efficacy of oncolytic viruses, departing f...
TFRI News|January 15, 2019 Dr. David Eisenstat appointed Alberta Node Leader for TFRI The Terry Fox Research Institute is pleased to announce the appointment of Dr. David Eisenstat as its new node leader for the Province of Alberta.
Research Highlight|January 14, 2019 Researchers discover common markers of tumour hypoxia across 19 cancer types The study, which was partially funded by the TFRI, investigated more than 8,000 human tumours across 19 different cancer types, including prostate tum...
Press Release|December 11, 2018 Outstanding researchers from Montreal, Halifax and Toronto receive $1.35 million to find new treatments for metastatic and ovarian cancers Three outstanding early-career investigators from Montreal, Halifax and Toronto will each receive $450,000 over the next three years to explore new tr...
Research Highlight|December 03, 2018 Identification of new lymphoma sub-group by Terry Fox Research Institute-funded cancer researchers opens door for potential new treatments for hard-to-treat cancer The discovery by BC researchers of a group of bad actors ‘hidden’ within a cohort of good ones may translate into new hope for cancer patients diagnos...
Event|November 14, 2018 TFRI BC Node researchers present their work during 2018 BC Cancer Summit The Terry Fox Research Institute's BC Node will host its annual Node Day on Friday, Nov. 23, 2018 at the Sheraton Wall Centre in Vancouver.
Event|October 16, 2018 Agenda posted for TFRI's Atlantic Node 2018 Cancer Research Conference The Terry Fox Research Institute's Atlantic Node and Beatrice Hunter Cancer Research Institute will be hosting their annual Cancer Research Conference...
TFRI News|October 01, 2018 2018 Terry Fox Run Challenge: TFRI teams show immense support, raise over $90k for research TFRI-funded researchers showed up in full force for the 38th annual Terry Fox Run, adding a splash of purple to run sites across the country and raisi...
Event|September 25, 2018 TFRI Ontario Node Day to be held on December 10, 2018 The Terry Fox Research Institute's Ontario Node will be holding its annual Research Symposium on December 10, 2018 at the MaRS Auditorium (conference ...
Research Highlight|September 10, 2018 Discovery of CD33 in human cord blood cells may affect design of targeted AML therapies This new discovery provides a possible explanation of why some trials that have used CD33 as a potential target for AML therapies have shown specific ...
Research Highlight|September 10, 2018 New discovery answers long-held question about myelodysplastic syndromes In a study published in Nature Communications (June 2018), a team led by Dr. Aly Karsan (BC Cancer) suggests that the key to understanding how both bo...
Research Highlight|September 10, 2018 Co-targeting EphA2/A3 reduces rGBM tumour growth in mice models A bi-specific antibody created by a TFRI-funded team has shown great promise in reducing tumour growth in patients with recurrent glioblastoma (rGBM).
Research Highlight|September 10, 2018 How do doctors really feel about active surveillance? A new study asking health care professionals why many men with low-risk prostate cancer opt for invasive treatments instead of active surveillance rev...
Research Highlight|September 10, 2018 Team identifies CDC25 as a common therapeutic target for triple-negative breast cancer Targeting CDC25 could bring hope to patients with RB1-deficient triple-negative breast cancer (TNBC), according to Toronto-based TFRI-funded team.
Research Highlight|September 10, 2018 Deep-sea bacteria inspire researchers to develop new ways to see, treat tumours The novel dual-biomimetic system created by a TFRI-funded team could serve as a contrast agent that allows researchers to see tumours more clearly, wh...
Research Highlight|September 10, 2018 Scientists use protein found in mosquito virus to suppress RNAi pathway, opening door to make oncolytic viruses more effective By using a protein from a virus first found in Japanese mosquitoes in the 1950s, TFRI-funded researchers have discovered a new way to bypass antiviral...
Event|August 04, 2018 TFRI launches 2018 Terry Fox Run Challenge To register a team for the Terry Fox Run 2018, please visit http://www.terryfox.org/run/teams/, or join our TFRI Headquarters team captained by Dr. Vi...
TFRI News|August 02, 2018 Pilot project network teams report steady progress in first year of working together Over the past year, the Terry Fox Canadian Comprehensive Cancer Centre Network (TF4CN) has fostered unprecedented collaborations, harmonized complex r...
Research Highlight|July 11, 2018 Leukemia researchers discover genetic screening tool to predict healthy people at risk of developing aggressive form of leukemia An international team of leukemia scientists that includes TFRI-funded researchers has discovered how to predict healthy individuals at risk of develo...
Research Highlight|July 01, 2018 MCC sub-project looks to identify biomarkers that could predict success of immunotherapy for leukemia patients A group of cancer investigators from some of the top research institutions in Montreal have come together to launch a groundbreaking project focused o...
Research Highlight|July 01, 2018 Montreal immunotherapy team studying ways to overcome treatment resistance in patients with melanoma Immunologist Dr. John Stagg (Université de Montréal, CR-CHUM) tells us how he and his team will contribute to a Montreal Cancer Consortium (MCC) initi...
Research Highlight|July 01, 2018 Project team in Montreal focuses on reducing side-effects, increasing effectiveness of immune therapies for melanoma patients Dr. Watson and his team are researching how the immune system interacts with melanoma, a disease that has been proven to respond favourably to anti-PD...
In the Media|June 28, 2018 Montreal Cancer Consortium created to develop new strategies Grouping of seven hospitals and research centres will focus on immunotherapy
TFRI News|June 28, 2018 The Terry Fox Research Institute and Montreal research partners form consortium to provide more personalized treatments for cancer patients in Québec Seeking to improve treatments for 18,000 annual cancer patients, leading researchers, cancer centres and hospitals in Montreal and The Terry Fox Resea...
Press Release|June 28, 2018 L’Institut de recherche Terry Fox et leurs partenaires de recherche de Montréal forment un consortium en vue d’offrir des traitements plus personnalisés aux personnes atteintes de cancer au Québec Dans le but d’améliorer les traitements offerts aux 18 000 patients atteints de cancer traités annuellement, les meilleurs chercheurs, centres de canc...
TFRI News|June 12, 2018 Celebrate failure! says TFRI’s leader in new book celebrating Chinese Canadians Dr. Victor Ling is among several prominent Chinese Canadians featured in a newly published 180-page, full-colour book titled Celebration: Chinese Cana...
Press Release|June 05, 2018 Trois des meilleures équipes de recherche canadiennes reçoivent 13 millions de dollars pour résoudre les principaux problèmes liés au cancer Drs. Greg Czarnota (Sunnybrook Health Sciences Centre), David Malkin (Hospital for Sick Children) and David Huntsman (BC Cancer, UBC) (Click here&nb...
TFRI News|June 05, 2018 Three top Canadian research teams receive $13 million to solve key cancer challenges Three outstanding cancer research teams will receive nearly $13 million to continue their investigations into rare tumours, an inherited disorder (Li-...
Research Highlight|June 01, 2018 Harmonizing T-cell production across multiple Canadian sites will potentially bring immunotherapy trials to more patients in more places Ovarian cancer patients across Canada may soon have access to promising immunotherapy trials thanks to a new collaboration fostered by The Terry Fox C...
Research Highlight|May 17, 2018 Erectile dysfunction drugs and flu vaccine may work together to help immune system fight cancer after surgery, study finds A new study led by Dr. Rebecca Auer, a member of TFRI's Oncolytic Virus project and former recipient of a TFRI New Investigator Award, suggests that a...
Research Highlight|May 15, 2018 Breakthrough test uses ctDNA to determine treatment resistance in advanced prostate cancer patients Metastatic castration-resistant prostate cancer (mCRPC) patients are now one step closer to more personalized treatment, thanks to a new test that can...
Research Highlight|May 15, 2018 Medulloblastoma leptomeningeal metastases can also occur through the bloodstream, study finds Findings from a recent study published in Cell are breaking new ground in the pediatric brain cancer world, suggesting medulloblastoma cells can metas...
Research Highlight|May 15, 2018 Researchers develop groundbreaking targeted sequencing pipeline to further precision medicine in lymphoid cancers A cancer research team funded partly by The Terry Fox Research Institute has identified the best method for sequencing gene mutations across several o...
Research Highlight|May 15, 2018 Targeting hypoxia can, in turn, target cancer-initiating cells in colorectal tumours Targeting hypoxia can, in turn, target cancer-initiating cells (C-ICs) in colorectal cancer a study team in Toronto has found. Additionally, the team ...
Research Highlight|May 15, 2018 Blocking donor T cell–mediated TNF? signaling can enhance positive effects of stem cell transplantation A collaboration between Swiss and Canadian research institutes has shown an effective way to enhance human hematopoietic stem and progenitor cell engr...
TFRI News|May 14, 2018 TFRI Now Seeking Applications for its 2019 Cancer Research Programs The Terry Fox Research Institute (TFRI) is seeking applications for two of its prestigious grant programs: The Terry Fox New Frontiers Program and the...
In the Media|May 13, 2018 Watch: TFRI New Investigator featured on CTV Manitoba Dr. Sachin Katyal (CancerCare Manitoba) talks about his unique approach to personalized medicine for brain cancer patients.
Research Highlight|May 10, 2018 TFRI-funded researchers uncover “evolutionary arms race” between cancer and immune system A new study led by a team of TFRI-funded researchers has uncovered the mechanisms through which deadly ovarian cancer cells escape the immune system, ...
Research Highlight|May 01, 2018 Canadian leaders in tumour hypoxia shed light on the role of mTOR signalling in prostate cancer development More findings from TFRI’s prestigious hypoxia team are continuing to change the cancer research landscape when it comes to understanding the role of t...
Event|April 26, 2018 Schedule announced for Atlantic Node's Workshop on "The Many Ways to Science" TFRI's Atlantic node and the Beatrice Hunter Cancer Research Institute will hold a joint workshop on May 25 for researchers and students in Atlantic C...
In the Media|April 11, 2018 Genetic sequencing brings new hope for North Vancouver woman Personalized treatment aids in pancreatic cancer recovery
TFRI News|March 07, 2018 Terry Fox Research Institute awards prestigious grant to help Manitoba cancer researcher tackle deadly brain cancer Brain cancer research in Manitoba has received a boost with news that a local scientist has won a prestigious cancer research award from the Terry Fox...
In the Media|March 06, 2018 New Canadian research aims for tailored treatment of pancreatic cancer Canadian scientists are teaming up with the Terry Fox Research Institute (TFRI) to lead a new $5-million personalized treatment initiative.
Press Release|March 06, 2018 Canadian pancreatic cancer research team provides personalized medicine, new hope to patients Canadian pancreatic cancer researchers are joining forces under a Terry Fox initiative bringing new hope for patients with this deadly disease.
Research Highlight|February 15, 2018 Therapeutic target EZH2 discovered for aggressive, untreatable ovarian cancer affecting young women A Vancouver team led by TFRI-funded investigator Dr. David Huntsman has discovered an important therapeutic target for treating small cell carcinoma o...
Research Highlight|February 15, 2018 Made-in-Canada model for detecting lung cancer saves lives, is a world leader A pan-Canadian TFRI team of cancer researchers has developed a predictive model for detecting early-stage lung cancer in high-risk individuals with si...
Research Highlight|February 15, 2018 Nuclear mTOR acts as a transcriptional regulator of metabolism in prostate cancer, groundbreaking study finds A recent study by TFRI’s cancer metabolism group suggests nuclear mTOR (a kinase) also works as a transcriptional regulator of metabolism in the proli...
Research Highlight|February 15, 2018 Vanadium compounds enhance efficacy of oncolytic viruses when used in combination therapy A new class of compounds is generating excitement for its ability to enhance the efficacy of oncolytic viruses (OVs) and to stimulate the immune respo...
Research Highlight|February 15, 2018 Ultrasound-stimulated microbubbles enhance radiation effect on prostate cancer cells What if there was a way to make cancer cells more susceptible to radiation therapy without damaging healthy cells? New findings from Toronto researche...
Press Release|February 15, 2018 Study finds mitochondrial mutations drive prostate cancer aggression While nuclear mutations are widely acknowledged as a driver of cancer tumours, the role of maternally inherited mitochondrial genome mutations has not...
TFRI News|February 08, 2018 2017 Marathon of Hope Lecture Series As part of its 10th anniversary celebration, TFRI presented a session titled The Marathon of Hope Lecture Series at the Canadian Cancer Research Confe...
Event|January 19, 2018 2017 TFRI Ontario Node Day Photos The annual Terry Fox Research Institute’s Ontario Node Research Symposium took place Monday, Dec. 4, 2017 at the MaRS Discovery Centre in Toronto. Ph...
Research Highlight|January 03, 2018 New study shows viruses and checkpoint inhibitors work together to cure resistant breast cancer in mice A new study led by TFRI-funded researchers at The Ottawa Hospital (TOH) and the University of Ottawa suggests that a combination of two immunotherapie...
TFRI News|December 07, 2017 Milestone Videos: TFRI Celebrates 10th Anniversary This was a big year for the Terry Fox Research Institute: 2017 marked our 10th anniversary. Here are two videos we created to celebrate this milestone...
Press Release|November 24, 2017 Canadian pediatric researchers, funders join forces, commit $16.4M to give young people across the country a fighting chance against cancer For the first time in Canadian history, more than 30 pediatric cancer research and funding organizations have joined forces through Terry Fox PROFYLE,...
In the Media|November 23, 2017 CancerCare Manitoba joins research project that offers hope for kids with rare cancers PROFYLE project brings together experts from across Canada to network, discover new treatments
In the Media|November 23, 2017 Canada-wide program aims to get young cancer patients faster access to new therapies If Terry Fox were diagnosed today, he would fall among the 20 per cent of young cancer patients who run out of treatment options. But now, patients li...
In the Media|November 23, 2017 Children out of cancer treatment options offered hope by new Terry Fox program 'It presents options and time,' says mother of 8-year-old girl now on new cancer drug
TFRI News|October 26, 2017 B.C. Lung Screen Trial recruiting 2,000 people for cancer screening study The B.C. Lung Screen Trial at Vancouver General Hospital is currently recruiting 2,000 individuals from the Lower Mainland who are between 55 and 80 y...
Research Highlight|October 18, 2017 Terry Fox research team’s model for detecting lung cancer saves lives, is a world leader: study A pan-Canadian team of cancer researchers has developed a predictive model for detecting early-stage lung cancer in high-risk individuals with signifi...
TFRI News|September 06, 2017 Four premier TFRI investigators will present Marathon of Hope talks at CCRC TFRI is pleased to announce that it will be presenting a concurrent session (D6 in program) at the upcoming Canadian Cancer Research Conference featur...
TFRI News|September 06, 2017 TFRI's 8th ASM focuses on potential of precision medicine TFRI’s one-day 8th Annual Scientific Meeting on Saturday, Nov. 4 in Vancouver will feature talks related to the theme of the potential of precision me...
TFRI News|September 06, 2017 It’s not too late to join a Terry Fox Run research team! The annual Terry Fox Run is just around the corner and our purple-shirted research teams, their friends and families will be out in full force again t...
Research Highlight|September 06, 2017 Canadian, international researchers find new candidate drivers, subtype diversity in study of whole-genome landscape for children’s brain cancer A new study has analyzed hundreds of sequenced medulloblastoma (MB) samples, identifying new targets that could give children with this disease less h...
Research Highlight|September 06, 2017 Vancouver team identifies new class of molecules with potential in treating metastatic prostate cancer A recent study by a prolific TFRI-funded team has demonstrated that disrupting ERG transcriptional activity is sufficient to suppress the major charac...
Research Highlight|September 06, 2017 Vaccine shows promise in models, eradicates intra-abdominal tumours in over 90 per cent of mice Ontario cancer researchers have found that an oncolytic virus may lead to a promising new therapy option for patients with peritoneal carcinomatosis, ...
Research Highlight|September 06, 2017 Why does relapse occur in aggressive leukemia? Canadian researchers crack the case A team of Canadian cancer researchers has shown that rare, therapy-resistant leukemia stem cells are already present at diagnosis in patients who expe...
Research Highlight|September 06, 2017 Study finds diffuse optical spectroscopic (DOS) texture features can predict breast cancer response prior to neoadjuvant chemotherapy Diffuse optical spectroscopic texture features can predict breast cancer response to neoadjuvant chemotherapy in locally advanced breast cancer patien...
Research Highlight|September 06, 2017 TP53 polymorphisms and MDM2 SNP309 are not correlated with pre-menopausal cancer risk, study suggests While significant accolades are given to scientists who discover genetic mutations that are linked to cancer, it is equally important to determine fac...
Research Highlight|September 06, 2017 Discovery of seven new ovarian cancer subtypes opens door for more targeted treatments The discovery of seven new genetic subtypes of ovarian cancer may lead to targeted treatments for women diagnosed with this disease, including those w...
Research Highlight|September 06, 2017 Subtype-specific alterations in BCL2 linked to poor post-treatment outcomes in non-Hodgkin lymphoma Subtype-specific alterations in a driver gene for non-Hodgkin lymphoma (BCL2) is strongly associated with poor patient outcomes after treatment.
Press Release|September 05, 2017 Three 2017 PPG awards announced for cutting-edge projects in leukemia, oncolytic viruses, nanoparticle imaging The Terry Fox Research Institute has invested nearly $21.5-million to renew three 2017 Terry Fox New Frontiers Program Project Grants (PPGs).
Event|August 28, 2017 Grab your running shoes: Join us on Sept. 17 for the annual Terry Fox Run This year's annual Terry Fox Run will be held at locations across Canada on Sunday, Sept. 17. Everyone is welcome to participate, regardless of age, a...
Research Highlight|July 01, 2017 Collaborative generation, sharing and analysis of data could make precision medicine available for patients with colorectal cancer The TF4CN is allowing scientists in two of Canada’s biggest cancer research centres to work together like never before to tackle four distinct project...
TFRI News|June 30, 2017 Canadian hero Terry Fox’s cancer research legacy lives on: VICE Sports Two features articles published by VICE Sports for Canada 150 are calling Terry Fox the most important athlete in Canadian history whose cancer resear...
Research Highlight|June 30, 2017 Lung cancer screening may save both lives and money, study suggests New research from a TFRI-funded team suggests screening for lung cancer could save money – and lives – especially if it also identifies other tobacco-...
TFRI News|June 22, 2017 One in two Canadians will get cancer, but research offers hope for cures Terry’s dream was to fund research to cure cancer, and he inspired us with that dream. We believe that it is through research that cures to cancer wil...
Research Highlight|June 07, 2017 ‘Better information helps make better decisions’: Research team takes prostate imaging to the next level In this blog post, Dr. Foster details the ground breaking work the group is doing in prostate cancer imaging through The Terry Fox New Frontiers Progr...
In the Media|May 29, 2017 Canada 150: Dr. Victor Ling made a huge breakthrough in fighting drug-resistant cancers In 1971, Dr. Victor Ling was frustrated and full of doubt. It was an unusual period for Ling, who is known for his optimism about finding a cure for c...
TFRI News|May 29, 2017 TFRI's Dr. Victor Ling recognized for breakthrough in fighting drug-resistant cancers Dr. Victor Ling, president and scientific director of The Terry Fox Research Institute, has been recognized by The Vancouver Sun for his breakthrough ...
Research Highlight|May 24, 2017 MATE2 expression a negative predictive biomarker to metformin’s efficacy in cancer treatment, study suggests The drug metformin is typically used to treat Type 2 diabetes, and some cancer patients have shown improved outcome when given the drug. A recent stud...
Research Highlight|May 24, 2017 Groundbreaking study sheds light on signaling molecules that control human hematopoietic stem cell survival and growth TFRI’s long-funded program project on human leukemia has made groundbreaking progress in the quest to expand human blood stem cells for therapeutic pu...
Research Highlight|May 24, 2017 Novel 17-gene test predicts if patients with aggressive leukemia will respond to treatment or not What if there was a way to predict if leukemia patients would respond to standard treatment or not? A TFRI-funded team has developed a novel, 17-gene ...
Research Highlight|May 24, 2017 Canadian study identifies predictive genomic signature for high-risk prostate cancer Understanding why some prostate cancer tumours are indolent while others eventually kill patients is the focus of many within the global cancer resear...
Research Highlight|May 24, 2017 Complement inhibitors decrease neutralization of some oncolytic viruses, increase treatment efficacy The use of oncolytic viruses to stimulate a patient’s immune system as well as directly kill tumour cells is a novel approach to eradicating cancer, b...
Research Highlight|May 18, 2017 B.C. team study detects rare ovarian cancer mutation in ctDNA of patients The finding by a B.C. team studying rare and forme fruste tumours is important in that it may help to identify women at risk of relapse for the diseas...
TFRI News|May 17, 2017 Terry Fox Foundation is media outlet’s top pick for donating to cancer research An article published in The National Post in mid-May has identified the Terry Fox Foundation as one of the best places to donate to cancer research in...
Event|April 28, 2017 Annual cancer research workshop sponsored by Beatrice Hunter Cancer Research Institute and the TFRI Atlantic Canada’s annual cancer research workshop Research and Collaboration in Oncology will be held May 26 in Halifax. The workshop will feature key...
Press Release|April 25, 2017 Four 2017 New Investigator award recipients announced Awards to four New Investigators were recently made, with each award valued at $450,000 for a term of three years. Recipients are: Dr. Housheng Hansen...
Research Highlight|March 24, 2017 New test identified to detect men at high risk of aggressive prostate cancer TFRI New Investigator Paul Boutros is among a team of researchers who have found a new test that can help to determine men at high risk for aggressive...
In the Media|February 23, 2017 Saint John to head national cancer study Oncologist and UNB Saint John professor picked by Terry Fox Research Institute
In the Media|February 22, 2017 Five-year study to examine treatments for people with multiple myeloma A New Brunswick led team has been awarded $5 million from the Terry Fox Research Institute to find better treatments for people with an incurable form...
TFRI News|February 15, 2017 TFRI launches Pan-Canadian initiative to bring new hope to multiple myeloma patients New Brunswick-led national research team aims for tailored treatments for patients with incurable multiple myeloma through Terry Fox Research Institut...
TFRI News|February 15, 2017 Cambridge MP Bryan May congratulates TFRI and partners in House of Commons In the House of Commons today, Cambridge MP Bryan May congratulated TFRI and its joint pilot project partners -- The Princess Margaret Cancer Centre a...
Press Release|February 02, 2017 The Terry Fox Research Institute, Princess Margaret Cancer Centre and BC Cancer Agency launch innovative pilot project to accelerate precision medicine in Canada The Terry Fox Research Institute and two leading cancer centres in Canada -- the Princess Margaret Cancer Centre and the BC Cancer Agency -- have l...
Research Highlight|January 04, 2017 Inexpensive algorithm will increase accuracy in subclassification of ovarian cancer, aid in matching treatment to histotype A biomarker study by COEUR (Canadian Ovarian Experimental Unified Resource), TFRI’s pan-Canadian ovarian cancer research team, examining over 2,000 ov...
Research Highlight|January 03, 2017 Hypoxia team members make game-changing findings about how tumour cells control oxygen consumption Members of TFRI’s hypoxia research team have made some game-changing findings when it comes to understanding how tumour cells regulate their ...
Research Highlight|January 03, 2017 TFRI-funded team identifies two new inhibitors that show potential in combination therapies for adult brain cancer A study by TFRI researchers investigating potential new drugs to treat glioblastoma (GBM) patients has identified an epigenetic-modifier drug which, t...
Research Highlight|January 03, 2017 How differences in the germline influence the type of prostate cancer that arises When it comes to treating prostate cancer, the news is predominantly positive: a combination of early detection and treatment by radiotherapy and surg...
Research Highlight|January 03, 2017 Personalizing treatment for patients with the most common malignant childhood brain tumour A TFRI-funded research team studying the most common type of brain tumour in children recently demonstrated the benefits of personalizing treatment ...
Research Highlight|January 03, 2017 Clusterin knockdown sensitizes prostate cancer cells to therapies by modulating mitosis A study by a TFRI-funded team based at the Vancouver Prostate Centre has found that silencing a key driver of castrate-resistant prostate cancer and r...
Research Highlight|December 14, 2016 Whole genome sequencing study helps BC team learn how aggressive follicular lymphoma occurs in patients Follicular lymphoma (FL), the second most common form of non-Hodgkin lymphoma, is a largely incurable disease of B cells, yet in many cases, because o...
Research Highlight|December 09, 2016 Stem cell-based test predicts leukemia patients' response to therapy to help tailor treatment TORONTO, Canada – Dec. 7, 2016 – Leukemia researchers at Princess Margaret Cancer Centre, with funding from Terry Fox and others, have developed a 17-...
Event|December 08, 2016 Ontario Node Symposium in Toronto draws large crowd; images posted TFRI's Ontario Node Research Symposium held on Monday, December 5 in Toronto drew over 400 people this year from across the province and beyond to hea...
Event|October 28, 2016 Joint 2016 BHCRI/TFRI Cancer Research Conference in Atlantic Canada set for November 7-8th in Halifax The Beatrice Hunter Cancer Research Institute and the Terry Fox Research Institute will hold their annual joint conference on November 7-8th at the Lo...
Research Highlight|October 05, 2016 How a unique zebrafish facility at Dalhousie is supporting two TFRI-funded projects Our current Zebrafish Core Facility is one of the largest of its kind in Canada and on par with the largest facilities in North America. We have the c...
TFRI News|September 29, 2016 2016 Terry Fox Run update: TFRI teams show immense support, with over $105,000 raised through team/t-shirt challenge TFRI-funded research teams from coast to coast showed their true colours this year, turning out by the dozens in researcher-designated purple T-shirts...
Research Highlight|September 29, 2016 Groundbreaking study finds miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells A groundbreaking new publication by Dr. John Dick’s TFRI-funded team has confirmed that miRNA expression patterns are predictive of disease outcome in...
Research Highlight|September 29, 2016 Montreal team discovers new molecular pathway key to understanding fat/cancer links A new publication from the TFRI-funded team at McGill University (Goodman Cancer Centre) studying oncometabolism and molecular pathways is bringing ne...
News|September 29, 2016 Dual expression study helps identify B-cell lymphoma patients at high risk for CNS relapse Despite improvements in outcome in diffuse large B-cell lymphoma (DLBCL) in the monoclonal antibody rituximab treatment era, central nervous system (C...
Research Highlight|September 29, 2016 Ovarian cancer: Mapping the clonal spread A team of B.C.-based, TFRI-funded scientists are breaking new ground with a recent study that tracked the clonal spread and intraperitoneal mixing of ...
Research Highlight|September 29, 2016 New class of small molecules enhances OV replication An innovative paper by Dr. Jean-Simon Diallo (TFRI-funded Canadian Oncolytic Virus Consortium (COVCo) and collaborators Drs. Jeffrey Smith and Christ...
Research Highlight|September 29, 2016 Ultrasound, imaging effective tools to monitor treatment response Terry Fox-funded researchers have made a critical finding in monitoring breast cancer patient response to chemotherapy treatment: patient response to ...
Press Release|September 07, 2016 TFRI ANNOUNCES 2016 FUNDING COMPETITION AWARD RECIPIENTS Vancouver, BC – Six outstanding Canadian research teams will use $27.3 million in new funding to engineer precision medicines for patients whose cance...
Research Highlight|July 15, 2016 “Smart” nanoparticle (PEARLs) a promising gem to target and treat tumours with greater precision Dr. Gang Zheng and a team of biomedical researchers have discovered a "smart," organic, biodegradable nanoparticle that uses heat and light in a contr...
Research Highlight|July 14, 2016 Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood International stem cell scientists, co-led in Canada by Terry Fox-funded scientist Dr. John Dick and in the Netherlands by Dr. Gerald de Haan, have di...
Research Highlight|June 14, 2016 Study by TFRI-funded team underscores importance of accurate diagnosis for rare ovarian and other cancers Terry Fox-funded cancer researchers in BC led an international study to develop a new method to improve diagnosis of a rare sub-type of ovarian cancer...
Research Highlight|June 04, 2016 Terry Fox researcher leads international conference on ‘devastating’ cancer predisposition syndrome Terry Fox-funded researcher Dr. David Malkin, The Hospital for Sick Kids, Toronto, Ontario, was in Columbus, Ohio this week to co-lead the 2016 Intern...
TFRI News|April 22, 2016 Dr. Victor Ling receives lifetime achievement award Congratulations to Dr. Victor Ling, TFRI's President and Scientific Director, who has been honoured with the LifeSciences BC Dr. Don Rix Award for Lif...
TFRI News|March 15, 2016 Rolland (Rolly) Murray Fox: 1935-2016 Rolland (Rolly) Murray Fox was born March 22, 1935 in Winnipeg, Manitoba. Rolly was the third of nine children born to Rodney Fox and Bertha (Shale) F...
TFRI News|March 09, 2016 A message from the Fox family: Rolly Fox Our Dad and Grandpa is no longer telling jokes. Rolland Murray Fox died late afternoon on March 8th while listening to a little Hank Williams. He fulf...
TFRI News|February 22, 2016 A message from Rolly Fox “I would like to express to all of the wonderful Terry Foxers in Canada and around the world, a heartfelt thank you for the many beautiful messages, l...
Research Highlight|February 12, 2016 Blue Light Shines Brightly as a Highly Useful Oral Cancer Surgery Tool Terry Fox-funded researchers find that fluorescence visualization may drastically reduce cancer recurrence by clearly differentiating cancer cells fro...
TFRI News|January 26, 2016 Rolly Fox - Fox family statement It is with heavy hearts that we wish to share with Terry Foxers from coast to coast and around the world that our Dad and Grandfather, Rolland (R...
Research Highlight|January 14, 2016 Biology of tumour changes when childhood brain cancer recurs, Canadian study finds New research co-funded by the Terry Fox Research Institute offers a simple explanation as to why new and experimental treatments fail for children wit...
TFRI News|November 19, 2015 Full house at 'Genomics and Cancer' Symposium Vancouver -- Around 350 people attended the Gairdner Foundation 'Genomics and Cancer' Symposium at UBC on 17 November. An international set of present...
TFRI News|November 10, 2015 Terry Fox researchers recognized for contributions to cancer research Montreal – TFRI extends their congratulations to two Terry Fox-funded researchers who received awards at this week’s Canadian Cancer Resea...
TFRI News|November 09, 2015 Researchers turn out for Terry Fox Morning Run Cancer researchers attending this year's Canadian Cancer Research Conference in Montreal rose early for the Terry Fox Early Morning Run. Darrell...
TFRI News|October 14, 2015 Terry Fox research team sets the bar high raising $35,000 in anniversary year To honour the 35th anniversary of the Marathon of Hope, many Terry Fox-funded research teams across Canada took up the challenge of fundraising for th...
TFRI News|September 21, 2015 Photos from the 35th anniversary Terry Fox Run Terry Fox-funded researchers from across the country took part in the 35th anniversary Terry Fox Run on Sept. 20, 2015. Here are a selection of photo...
Press Release|September 16, 2015 $16-million from supporters and partners fuels research to improve detection, treatment for high-risk, inherited cancers In this 35th anniversary year of the Terry Fox Marathon of Hope, a $16-million injection of funding from the Terry Fox Foundation and three new resear...
In the Media|September 11, 2015 FOX 35: Vitamin C crucial part of cancer breakthrough – funded by Fox Could Vitamin C restore the balance to the epigenome in the blood cancer and become a therapeutic benefit to help those in need?
TFRI News|September 04, 2015 Darrell Fox cycling to Mount Terry Fox September 4, 2015 -- Darrell Fox is cycling 350km from Kamloops to Valemount ahead of the Fox Family hike up Mount Terry Fox on Sunday, September 6. ...
TFRI News|September 02, 2015 Fox Family to hike to summit of Mount Terry Fox The family of Canadian icon Terry Fox will reflect on 35 years of dedication to cancer research and Terry’s memory when they and 50-plus “Terry Foxers...
TFRI News|August 31, 2015 Terry Fox Run 2015 The 2015 Terry Fox Run takes place on Sunday, September 20. Many Terry Fox-funded research teams have signed-up to mark the 35th anniversary of Terry'...
TFRI News|August 26, 2015 Quebec researchers to fight a deadly form of children’s leukemia and to test a new way to kill prostate cancer cells Terry Fox spent months in a pediatric ward for his bone cancer. Today, two of three Quebec researchers to receive funding from Terry Fox will pursue n...
Press Release|August 19, 2015 TFRI BC researchers aim to improve treatment, diagnostics for leukemia and lymphoma Vancouver, BC --Terry Fox’s research legacy continues in British Columbia 35 years after he set out on his Marathon of Hope. Two local cancer research...
Press Release|August 19, 2015 Studying bone cancer in dogs may yield new therapies for treating osteosarcoma patients Guelph, Ontario - For the first time, funds raised for cancer research by the Terry Fox Foundation through the annual Terry Fox Run will be used to st...
TFRI News|August 05, 2015 Manitoba marks first Terry Fox Day Manitoba marked the first Terry Fox Day on August 3, 2015. Terry was born in Winnipeg, MB, in 1958 and the province is the first to name a day in his ...
Research Highlight|July 24, 2015 Supporting future leaders in cancer research in Atlantic Canada *This article by Dr. Alamelu Bharadwaj is part of the old TFRI Blog. Basic science research is complex and time consuming but is the most ...
In the Media|July 10, 2015 Canadian study to use two cancer-fighting viruses in world first Ontario researchers have launched the first clinical trial that will use two, custom-made, cancer-fighting viruses to stimulate the immune system into...
Research Highlight|July 10, 2015 Cancer patients treated in world-first clinical trial of viral therapy Terry Fox-funded researchers are key members of a Canadian team to have launched the world’s first clinical trial of a new therapy that uses a combina...
TFRI News|June 08, 2015 Ontario legislature supports Terry Fox Day The Ontario legislature has completed third reading of a bill calling for the second Sunday after Labour Day to be designated Terry Fox Day. Ontario M...
TFRI News|June 05, 2015 BC Node hosts MLAs Victoria , BC May 26 -- BC MLAs and ministers had an opportunity to hear about the current state of cancer research from TFRI-BC Node Regional Advisor...
TFRI News|May 27, 2015 Support grows for a space to share Terry's story The Fox family have enlisted the head of credit union Vancity to investigate options for a centre to honour Terry Fox and to display the thousands of ...
TFRI News|May 26, 2015 TFRI Prairie Node Symposium Day The TFRI Prairie Node Symposium Day took place on June 9, 2015 in Winnipeg, MB. Nearly 100 people attended the event, hosted by Prairies Node lea...
TFRI News|May 12, 2015 Annual Scientific Meeting Over 200 researchers enjoyed warm Newfoundland hospitality when they attended TFRI's 6th Annual Scientific Meeting in St. John's Newfoundland.
Research Highlight|April 23, 2015 Viruses and drugs combine to form potent anti-cancer therapy Ottawa, ON -- Terry Fox-funded researcher, Dr. Jean-Simon Diallo and his colleagues at the Ottawa Hospital Research Institute have discovered that com...
Research Highlight|April 20, 2015 Pancreatic cancer loses viral defences when talking with supporting cells Ottawa, ON -- Terry Fox funded researchers in Ottawa have found a way to make pancreatic cancer cells more vulnerable to cancer-killing viruses, known...
TFRI News|April 13, 2015 $35 million goal for Marathon of Hope Anniversary This weekend marked the 35th anniversary of the start of Terry Fox's Marathon of Hope, when he set off from St. John's NL on April 12, 1980. In the 35...
TFRI News|April 07, 2015 Museum of History - Terry Fox exhibit To mark the 35th anniversary of Terry Fox's Marathon of Hope, the Canadian Museum of History has opened a special exhibit Terry Fox - Running to the H...
TFRI News|January 15, 2015 Congratulations to TFRI researcher on $25 million funding for cancer biotherapeutics initiative The Terry Fox Research Institute congratulates Dr. John Bell and his team on their award of $25 million in funding from the Government of Canada's Net...
TFRI News|December 09, 2014 Ontario Node Symposium Day Over 260 people attended the first TFRI-Ontario Node Research Symposium on Monday, Dec. 8, at the the MaRS Discovery Centre, Toronto.
TFRI News|November 24, 2014 The Terry Fox Foundation welcomes Britt Andersen as new Executive Director The Terry Fox Foundation is pleased to announce the appointment of Britt Andersen as its new Executive Director, effective November 24, 2014.
TFRI News|November 14, 2014 Taiwan President Ma Ying-jeou will join Darrell Fox and West Vancouver MP John Weston in Taipei Terry Fox Run The Terry Fox Foundation (TFF) is pleased to announce that Taiwan President Ma Ying-jeou will participate in the Terry Fox Run being held in Taipei, T...
Research Highlight|November 13, 2014 Glioblastoma team makes good progress with nine compounds in the pipeline Calgary, Alberta -- Glioblastoma (GBM) is a deadly adult brain cancer that has eluded major treatment advances. Our Terry Fox pan-Canadian project, le...
TFRI News|October 23, 2014 BC legislature supports Terry Fox Day Victoria, BC Oct. 23, 2014 -- BC legislature calls for the second Sunday after Labour Day to be designated Terry Fox Day
TFRI News|October 23, 2014 TFRI and Team Finn Foundation form partnership TFRI and the Team Finn Foundation have formed a new partnership to build a business plan for a new research initiative focused on young persons’ canc...
Press Release|September 10, 2014 $14.6-million investment kicks off 2014 Terry Fox Run Terry Fox Foundation takes aim at hard-to-treat cancers and personalized treatment with multimillion-dollar research investment at six leading Toronto...
TFRI News|July 28, 2014 Staff, management at Montreal hotel donate $1,000 to Terry Fox research TFRI’s fifth annual scientific meeting (ASM) in Montreal, Quebec this spring wrapped up with a surprise cash donation of a $1,000 for Terry Fox resear...
Press Release|March 06, 2014 Innovative new investigators to study cancer growth and response to treatment Three promising Canadian cancer researchers, two in Ontario and one in Quebec, have been awarded a total of $1.35 million under the Terry Fox Research...
Research Highlight|February 17, 2014 Terry Fox-funded lymphoid cancer group discovers new, recurrent genetic mutation in two kinds of lymphoma Researchers funded by the Terry Fox Foundation and based at the BC Cancer Agency’s Centre for Lymphoid Cancer in Vancouver have discovered a new, recu...
TFRI News|October 28, 2013 Canadian Cancer Research Alliance honours Dr. Ling with Exceptional Leadership in Cancer Research award TFRI’s president and scientific director Dr. Victor Ling will be recognized at an awards dinner on Nov. 5th in Toronto for his Exceptional Leadership ...
TFRI News|October 09, 2013 The Terry Fox Foundation tackles "unmet cancer needs" with $13.6-million for rare tumour, lymphoma and early-stage prostate and esophogeal cancer research The Terry Fox Foundation tackles "unmet cancer needs" with $13.6-million for rare tumour, lymphoma and early-stage prostate and esophogeal cancer rese...
Press Release|September 05, 2013 Terry Fox Research Institute-Led Study Develops New Clinical Tool That Accurately Classifies, Nine Out Of Ten Times, Benign And Malignant Spots On Lung CT Scans Of Smokers Terry Fox Research Institute-Led study develops new clinical tool that accurately classifies, nine out of ten times, benign and malignant spots on lun...
In the Media|September 04, 2013 Made-in-Canada software helps better predict cancerous lesions in CT scans A team of Canadian researchers led by the Terry Fox Research Institute has developed new software that can accurately identify whether a lesion on the...
Research Highlight|June 27, 2013 Study extended to June 2015 Study extended to June 2015. The Terry Fox Research Institute and partners inject $1.5 million into national lung cancer study to answer additional ke...
TFRI News|April 10, 2013 Terry Fox Research Institute and Saskatchewan Health Research Foundation Partner On Innovative Tumour-Targeting Terry Fox Research Institute and Saskatchewan Health Research Foundation Partner On Innovative Tumour-Targeting Approach For Treating Cancer
Press Release|October 11, 2012 The Terry Fox Foundation provides $13.4 million for world-class, novel research into fighting cancer with viruses The Terry Fox Foundation provides $13.4 million for world-class, novel research into fighting cancer with viruses and finding ways to treat acute leuk...
TFRI News|September 06, 2012 New national initiative unites university students from coast to coast in honour of Canadian hero Terry Fox's legacy for cancer research New national initiative unites university students from coast to coast in honour of Canadian hero Terry Fox's legacy for cancer research
TFRI News|July 25, 2012 New pan-Canadian Terry Fox Research Institute network receives close to $4-million to find better tools to treat prostate cancer New pan-Canadian Terry Fox Research Institute network receives close to $4-million to find better tools to treat prostate cancer
TFRI News|July 09, 2012 2011 New Investigator awardees receive $1.7 million 2011 New Investigator awardees receive $1.7 million
TFRI News|June 26, 2012 McGill trainees earn top honours at TFRI Scientific Meeting Poster Competition McGill trainees earn top honours at TFRI Scientific Meeting Poster Competition
Press Release|June 05, 2012 Canadian "dream team" to tackle deadly brain cancer with $8.2 million from The Terry Fox Research Institute Canadian "dream team" to tackle deadly brain cancer with $8.2 million from The Terry Fox Research Institute, The Terry Fox Foundation and its partners...
TFRI News|May 01, 2012 Terry Fox Research Institute announces appointment of Iain R.V. MacKay to its Board of Directors Terry Fox Research Institute announces appointment of Iain R.V. MacKay to its Board of Directors
Research Highlight|April 01, 2012 Terry-Fox funded research at Princess Margaret Hospital finds oxygen in tumours predicts prostate cancer recurrence Terry-Fox funded research at Princess Margaret Hospital finds oxygen in tumours predicts prostate cancer recurrence
TFRI News|March 21, 2012 Terry Fox inducted into Canadian Medical Hall of Fame as "medical hero" Terry Fox inducted into Canadian Medical Hall of Fame as "medical hero"
News|February 22, 2012 Signing in Singapore strengthens research capacity and Terry Fox legacy Signing in Singapore strengthens research capacity and Terry Fox legacy
Press Release|February 06, 2012 Study will identify tumour subtypes for better treatment. TFRI invests $750,000 in national childhood brain cancer project Study will identify tumour subtypes for better treatment. TFRI invests $750,000 in national childhood brain cancer project
TFRI News|February 06, 2012 Queen's Diamond Jubilee Medal honours legacy of Terry Fox Queen's Diamond Jubilee Medal honours legacy of Terry Fox
TFRI News|December 12, 2011 BC surgeon Dr. Nadine Caron delivers keynote address at inaugural TFRI-BC Node Research Day BC surgeon Dr. Nadine Caron delivers keynote address at inaugural TFRI-BC Node Research Day
TFRI News|December 10, 2011 Scientists brave heavy rain in Toronto to run in memory of Betty Fox Scientists brave heavy rain in Toronto to run in memory of Betty Fox
TFRI News|November 02, 2011 Terry Fox Run dollars provide $12.7 million to Canadian scientists and health research centres for breakthrough cancer research Terry Fox Run dollars provide $12.7 million to Canadian scientists and health research centres for breakthrough cancer research
TFRI News|October 13, 2011 New Terry Fox Research Institute initiative seeks to change the way ovarian cancer is diagnosed and managed worldwide New Terry Fox Research Institute initiative seeks to change the way ovarian cancer is diagnosed and managed worldwide
Press Release|May 26, 2011 Pan-Canadian Surgical Study Offers New Hope for Patients with Early-Stage Oral Cancer Pan-Canadian Surgical Study Offers New Hope for Patients with Early-Stage Oral Cancer
Research Highlight|April 20, 2011 Ottawa resident receives excellent prognosis after study detects early lung cancer Ottawa resident receives excellent prognosis after study detects early lung cancer
Research Highlight|April 12, 2011 Investment helps novel drug for colorectal cancer move forward into clinical trial to determine tolerability for patients Investment helps novel drug for colorectal cancer move forward into clinical trial to determine tolerability for patients
TFRI News|December 08, 2010 Terry Fox Foundation awards four promising new investigators with nearly $2 million Terry Fox Foundation awards four promising new investigators with nearly $2 million
TFRI News|December 02, 2010 TFRI Launches Prairie Node on Thursday Dec. 2, 2010 TFRI Launches Prairie Node on Thursday Dec. 2, 2010
Press Release|September 16, 2010 The Terry Fox Foundation announces $14.8-million national investment in cancer research through new partnership The Terry Fox Foundation announces $14.8-million national investment in cancer research through new partnership with Canadian Institutes of Health Res...
Press Release|September 08, 2010 Genome sciences leader Dr. Marco Marra joins executive team of the Terry Fox Research Institute Genome sciences leader Dr. Marco Marra joins executive team of the Terry Fox Research Institute
TFRI News|June 23, 2010 Terry Fox Research Institute Expands Early Detection Lung Study to Newfoundland & Labrador Terry Fox Research Institute Expands Early Detection Lung Study to Newfoundland & Labrador
Press Release|June 21, 2010 Excellence and Terry's story inspires inaugural TFRI poster award winner Excellence and Terry's story inspires inaugural TFRI poster award winner
Press Release|April 12, 2010 Improving Cancer Outcomes Through Translational Research Is Priority For New Terry Fox Research Institute Node and Atlantic Partners Improving Cancer Outcomes Through Translational Research Is Priority For New Terry Fox Research Institute Node and Atlantic Partners